Brief: Inozyme Pharma Reports Second Quarter 2023 Financial Results

Inozyme Pharma

08/08/2023 14:29

Aug 8 (Reuters) - Inozyme Pharma Inc  INZY.O :
    * INOZYME PHARMA REPORTS SECOND QUARTER 2023 FINANCIAL
RESULTS AND
PROVIDES BUSINESS HIGHLIGHTS
    * CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS AS OF
JUNE
30, 2023
    * INOZYME PHARMA-CASH, CASH EQUIVALENTS, SHORT-TERM
INVESTMENTS &
PROCEEDS FROM JULY 2023 OFFERING, EXPECTED TO FUND CASH FLOW
REQUIREMENTS INTO Q4 2025
    * QTRLY NET LOSS PER SHARE $0.35
    * Q2 EARNINGS PER SHARE VIEW $-0.43 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX9DhDqd 
Further company coverage:  INZY.O